A team of BioNTech alumni thinks cancer screening has been stuck in the past, and it has raised $25M to do something about it. Bios Life has emerged from stealth with a plan to replace one-off screening with continuous, AI-driven surveillance, and a data alliance with Tempus to power it.
Source: [TNW](https://thenextweb.com/news/bios-life-25m-ai-cancer-surveillance-tempus)